Precision treatment in advanced hepatocellular carcinoma
#1PRI RANKED
Most Cited Paper
in Hepatocellular Carcinoma Treatment and Prognosis
18 Months Post-Publication
Class of 2026
“Precision treatment in advanced hepatocellular carcinoma”
A research intelligence initiative by Pepkio
pri.pepkio.com/top-papers/hepatocellular-carcinoma-treatment-and-prognosis/2026/
Topics
Hepatocellular carcinoma · Precision medicine · Advanced hepatocellular carcinoma · Targeted therapy · Biomarker · molecular subtypes · sorafenib · lenvatinib · Immune checkpoint inhibitor therapy · PD-1/PD-L1 inhibitor · Tumor microenvironment · Genomics · VEGF signaling pathway · mTOR pathway · TERT promoter mutation · TP53 mutation · CTNNB1 mutation · MET amplification · FGF19 amplification · Systemic therapy · Combination therapy · atezolizumab · bevacizumab · patient stratification · Predictive biomarker · tumor mutational burden · microsatellite instability · Hepatocellular carcinoma · next-generation sequencing · clinical outcomes
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited Hepatocellular Carcinoma Treatment and Prognosis Papers, Class of 2026. https://pri.pepkio.com/top-papers/hepatocellular-carcinoma-treatment-and-prognosis/2026. Accessed 2026-07-13. Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459